Section

Oxford Biomedica posts strong revenue growth in first half results

By Daily Mail - a month ago
OXB maintained its 2024 earnings outlook after reporting strong revenue growth in the first half of the year.

Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.